World Orphan Drug Congress USA focusses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster.
World Orphan Drug Congress USA has evolved from a one track conference focused on regulatory pathways, policy and incentives, to a global gathering of 1,000 leaders in orphan drugs from 38 countries, and over 135 presentations covering all aspects of orphan drug development and rare disease research.
Enjoy discussions on:
Cell & Gene Therapies
Partnering & Investment
Global Market Access
Expanded Access Programs
Real World Evidence
Global Patient Advocacy
Value based pricing & reimbursement
Epidemiology & forecasting
Orphan Drugs Policy
Gene Therapy Development
Your customers are here continuously looking for new strategies and technologies to expedite orphan drugs to patients.
Find out how World Orphan Drug Congress USA can solve all your sales and marketing needs.
Are you a rare disease biotech who's looking for funding or partnership/co-development/licensing opportunities?
Applications for Pitch & Partner 2018 are now open and only 30 biotechs will be selected to present to prospective investors and partners!
AccessPharmaCon,LLC Aegerion Pharmaceuticals Aetna Pharmacy Management Alexion Pharmaceuticals Andarix Pharmaceuticals ArmaGen Technologies, Inc. Ashfield Healthcare Asklepion Pharmaceuticals LLC Ax-S Pharma B.D.C. Venture Capital BioBlast Pharma Ltd Biomarin Pharmaceutical Inc. BioPontis Alliance for Rare Disease Brace Pharma Capital Brazilian Federal Council of Medicine Bristol-Myers Squibb CatalentPharma Solutions CatalystPharmaceutical Partners CDER FDA Clear Pharma Clementia Pharmaceuticals Inc. Clinuvel Pharmaceuticals Ltd Dicerna Pharmaceuticals DrugDev EvaluatePharma Ltd Genoa Pharmaceuticals Genpharm GenSight Biologics Genzyme Corp Giddi Pharma Co., Ltd. Idera Pharmeceuticals IDIS Pharma Iptechex Pharmalicensing Jazz Pharmaceuticals, Inc Juice Pharma Worldwide KBI Biopharma Inc Lumos Pharma M3 Pharma Marathon Pharmaceuticals LLC Marinus Pharmaceuticals Momenta Pharmaceuticals Inc Opsona Therapeutics Ltd Optio Biopharma Solutions LLC Orpharma Pfizer, Inc Pharmaceutics International In Pharmaessentia Corp Pharnext Portola Pharmaceuticals , Inc. Provectus PharmaceuticalsInc QuayPharma Quintiles Inc Raptor Pharmaceuticals Corp Reata Pharmaceuticals Recordati S.p.A Recursion Pharmaceuticals Retrophin Sanofi Savara Pharmaceuticals Seattle Children's Research Institute Shire Pharmaceuticals Inc Taiba Pharma LLC Teva Threshold Pharmaceuticals Inc Tolero Pharmaceuticals Ultragenyx Pharmaceutical Inc. Valley Fever Solutions Vanda Pharmaceuticals Inc Vertex Pharmaceuticals